Lila Sciences
Autonomous AI science factories for drug discovery
Lila Sciences is building 'scientific superintelligence' through autonomous AI-powered research labs called AI Science Factories. Incubated by Flagship Pioneering and unveiled in March 2025, the company uses AI and robotics to autonomously conduct scientific experiments across life sciences. Lila aims to generate genetic medicines and discover new antibodies at unprecedented scale, with NVIDIA NVentures backing its vision of fully autonomous drug discovery.
Platform, Foundation Models, Target Discovery
Funding
$550M
Total raised
$115M
Led by NVIDIA NVentures
Flagship Pioneering · NVIDIA NVentures · General Catalyst
Technology
AI Science Factories — fully autonomous wet-lab + AI research platforms that design, execute, and analyze scientific experiments without human intervention. The system combines robotic lab automation with proprietary AI models to explore vast biological hypothesis spaces at machine speed.
Leadership
Geoffrey von Maltzahn
CEO
Flagship Pioneering platform leader, MIT-trained biomedical engineer
Similar companies
Bioptimus
Universal biology foundation model from ex-DeepMind team
platform · 2024BenevolentAI
AI-enabled knowledge graph for drug discovery and repurposing
clinical · 2014Boltz PBC
Open-source biomolecular AI for drug discovery
platform · 2026Calico Life Sciences
Alphabet-backed research into the biology of aging
clinical · 2013Get updates on Lila Sciences
We'll notify you when we publish updates about Lila Sciences.